Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma
A 56-year-old male was treated by local surgery in 1968 and 2005 for a left thigh lesion. A 2nd local relapse occurred in 2015 and was treated by complete macroscopic surgery with histology concluding to a hidradenocarcinoma. A 3rd locoregional relapse occurred in October 2018, with the presence of...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2020/9656475 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547719287144448 |
|---|---|
| author | S. Korbi H. Rachdi H. El Benna N. Mejri Y. Berrazaga N. Daoud S. Labidi H. Boussen |
| author_facet | S. Korbi H. Rachdi H. El Benna N. Mejri Y. Berrazaga N. Daoud S. Labidi H. Boussen |
| author_sort | S. Korbi |
| collection | DOAJ |
| description | A 56-year-old male was treated by local surgery in 1968 and 2005 for a left thigh lesion. A 2nd local relapse occurred in 2015 and was treated by complete macroscopic surgery with histology concluding to a hidradenocarcinoma. A 3rd locoregional relapse occurred in October 2018, with the presence of inflammatory ulcerated lesions. A 2nd histology and immunohistochemistry exam showed a proliferation positive for CK, CK5, and p63 suggesting the diagnosis of hidradenocarcinoma. The patient was treated by 3 lines of chemotherapy, 1st by Adriamycin, 2nd by carboplatin-paclitaxel, and then 3rd by oral capecitabine, leading to a stable clinical disease but without a clinical benefit. A locoregional plus metastatic lung progression was observed in March 2019, with the presence of lung nodules and retroperitoneal lymph nodes, multiple skin left thigh and left inguinal ulcerated lesions. The patient received then in 4th line in April 2019 oral sunitinib at 50 mg daily, with 4 weeks therapy/2 weeks pause. Side effects were represented by mucositis, anorexia, weight loss, and fatigue. We observed since the 1st week of therapy a fast response, with a decrease of the ulcerated lesions, a skin loss, and deep hemorrhagic areas. CT-scan showed after 2 weeks of sunitinib an objective response on both locoregional and metastatic lesions. |
| format | Article |
| id | doaj-art-906e1f70798745eaaf1f762525fa2846 |
| institution | Kabale University |
| issn | 2090-6706 2090-6714 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Oncological Medicine |
| spelling | doaj-art-906e1f70798745eaaf1f762525fa28462025-02-03T06:43:39ZengWileyCase Reports in Oncological Medicine2090-67062090-67142020-01-01202010.1155/2020/96564759656475Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh HidradenocarcinomaS. Korbi0H. Rachdi1H. El Benna2N. Mejri3Y. Berrazaga4N. Daoud5S. Labidi6H. Boussen7Medical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaMedical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaMedical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaMedical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaMedical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaMedical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaMedical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaMedical Oncology Department, University Hospital Abderrahman Mami, Ariana, Boulevard de l’Hopital, 2080 Tunis, TunisiaA 56-year-old male was treated by local surgery in 1968 and 2005 for a left thigh lesion. A 2nd local relapse occurred in 2015 and was treated by complete macroscopic surgery with histology concluding to a hidradenocarcinoma. A 3rd locoregional relapse occurred in October 2018, with the presence of inflammatory ulcerated lesions. A 2nd histology and immunohistochemistry exam showed a proliferation positive for CK, CK5, and p63 suggesting the diagnosis of hidradenocarcinoma. The patient was treated by 3 lines of chemotherapy, 1st by Adriamycin, 2nd by carboplatin-paclitaxel, and then 3rd by oral capecitabine, leading to a stable clinical disease but without a clinical benefit. A locoregional plus metastatic lung progression was observed in March 2019, with the presence of lung nodules and retroperitoneal lymph nodes, multiple skin left thigh and left inguinal ulcerated lesions. The patient received then in 4th line in April 2019 oral sunitinib at 50 mg daily, with 4 weeks therapy/2 weeks pause. Side effects were represented by mucositis, anorexia, weight loss, and fatigue. We observed since the 1st week of therapy a fast response, with a decrease of the ulcerated lesions, a skin loss, and deep hemorrhagic areas. CT-scan showed after 2 weeks of sunitinib an objective response on both locoregional and metastatic lesions.http://dx.doi.org/10.1155/2020/9656475 |
| spellingShingle | S. Korbi H. Rachdi H. El Benna N. Mejri Y. Berrazaga N. Daoud S. Labidi H. Boussen Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma Case Reports in Oncological Medicine |
| title | Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma |
| title_full | Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma |
| title_fullStr | Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma |
| title_full_unstemmed | Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma |
| title_short | Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma |
| title_sort | objective clinical and radiological response under sunitinib in a case of thigh hidradenocarcinoma |
| url | http://dx.doi.org/10.1155/2020/9656475 |
| work_keys_str_mv | AT skorbi objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma AT hrachdi objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma AT helbenna objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma AT nmejri objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma AT yberrazaga objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma AT ndaoud objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma AT slabidi objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma AT hboussen objectiveclinicalandradiologicalresponseundersunitinibinacaseofthighhidradenocarcinoma |